Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Silo Pharma, Inc. issued 848,320 shares of Common Stock of common stock to investor relations consultant for commitment fee of $250,000.
- Security
- common stock
- Shares
- 848,320 shares of Common Stock
- Purchaser
- investor relations consultant
- Consideration
- commitment fee of $250,000
Exact text from the filing
On February 20, 2026, Silo Pharma, Inc. (the “Company”) entered into an addendum to Service Agreement with its investor relations consultant pursuant to which is agreed to pay such consultant a commitment fee of $250,000 (the “Commitment Fee”) in consideration of entering into the addendum and restarting the service agreement. The consultant elected to receive the Commitment Fee in shares of the Company’s common stock, par value $0.0001 per share (“Common Stock”) resulting in 848,320 shares of Common Stock payable to the consultant in respect of the Commitment Fee based on a $0.2947 share price
View on SEC.gov